 | • レポートコード：MRC2Q12-19198 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品＆医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、注射用ロルノキシカムのグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 注射用ロルノキシカムのアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 注射用ロルノキシカムの中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 注射用ロルノキシカムのヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までの注射用ロルノキシカムの生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の注射用ロルノキシカムの売上および2028年までの予測に焦点を当てています。 注射用ロルノキシカムのグローバル主要企業には、Suzhou Tianma Pharma Group、Zhejiang Zhenyuan Pharmaceutical、Beijing Polay Pharmaceuticals、Harbin Medisan Pharmaceutical、Hainan Jinrui Pharmaceutical、FLAGSHIP BIOTECH、Swissche Healthcare、Wasserbuger Artneimittelwerk GmbH、Takeda Austria GmbHなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 注射用ロルノキシカム市場は、タイプとアプリケーションによって区分されます。世界の注射用ロルノキシカム市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 6本/ボトル、8本/ボトル、10本/ボトル 【アプリケーション別セグメント】 病院薬局、小売店薬局、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 注射用ロルノキシカム製品概要 - タイプ別市場（6本/ボトル、8本/ボトル、10本/ボトル） - アプリケーション別市場（病院薬局、小売店薬局、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の注射用ロルノキシカム販売量予測2017-2028 - 世界の注射用ロルノキシカム売上予測2017-2028 - 注射用ロルノキシカムの地域別販売量 - 注射用ロルノキシカムの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別注射用ロルノキシカム販売量 - 主要メーカー別注射用ロルノキシカム売上 - 主要メーカー別注射用ロルノキシカム価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（6本/ボトル、8本/ボトル、10本/ボトル） - 注射用ロルノキシカムのタイプ別販売量 - 注射用ロルノキシカムのタイプ別売上 - 注射用ロルノキシカムのタイプ別価格 ・アプリケーション別市場規模（病院薬局、小売店薬局、その他） - 注射用ロルノキシカムのアプリケーション別販売量 - 注射用ロルノキシカムのアプリケーション別売上 - 注射用ロルノキシカムのアプリケーション別価格 ・北米市場 - 北米の注射用ロルノキシカム市場規模（タイプ別、アプリケーション別） - 主要国別の注射用ロルノキシカム市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの注射用ロルノキシカム市場規模（タイプ別、アプリケーション別） - 主要国別の注射用ロルノキシカム市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の注射用ロルノキシカム市場規模（タイプ別、アプリケーション別） - 主要国別の注射用ロルノキシカム市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の注射用ロルノキシカム市場規模（タイプ別、アプリケーション別） - 主要国別の注射用ロルノキシカム市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの注射用ロルノキシカム市場規模（タイプ別、アプリケーション別） - 主要国別の注射用ロルノキシカム市場規模（トルコ、サウジアラビア） ・企業情報 Suzhou Tianma Pharma Group、Zhejiang Zhenyuan Pharmaceutical、Beijing Polay Pharmaceuticals、Harbin Medisan Pharmaceutical、Hainan Jinrui Pharmaceutical、FLAGSHIP BIOTECH、Swissche Healthcare、Wasserbuger Artneimittelwerk GmbH、Takeda Austria GmbH ・産業チェーン及び販売チャネル分析 - 注射用ロルノキシカムの産業チェーン分析 - 注射用ロルノキシカムの原材料 - 注射用ロルノキシカムの生産プロセス - 注射用ロルノキシカムの販売及びマーケティング - 注射用ロルノキシカムの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 注射用ロルノキシカムの産業動向 - 注射用ロルノキシカムのマーケットドライバー - 注射用ロルノキシカムの課題 - 注射用ロルノキシカムの阻害要因 ・主な調査結果 |
Market Analysis and Insights: Global Lornoxicam for Injection Market
Due to the COVID-19 pandemic, the global Lornoxicam for Injection market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, 6 Pcs/Bottle accounting for % of the Lornoxicam for Injection global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital Pharmacy segment is altered to an % CAGR throughout this forecast period.
China Lornoxicam for Injection market size is valued at US$ million in 2021, while the US and Europe Lornoxicam for Injection are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Lornoxicam for Injection landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Lornoxicam for Injection include Suzhou Tianma Pharma Group, Zhejiang Zhenyuan Pharmaceutical, Beijing Polay Pharmaceuticals, Harbin Medisan Pharmaceutical, Hainan Jinrui Pharmaceutical, FLAGSHIP BIOTECH, Swissche Healthcare, Wasserbuger Artneimittelwerk GmbH and Takeda Austria GmbH. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Lornoxicam for Injection Scope and Segment
Lornoxicam for Injection market is segmented by Specification and by Application. Players, stakeholders, and other participants in the global Lornoxicam for Injection market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Specification and by Application for the period 2017-2028.
Segment by Specification
6 Pcs/Bottle
8 Pcs/Bottle
10 Pcs/Bottle
Segment by Application
Hospital Pharmacy
Retail Pharmacy
Others
By Company
Suzhou Tianma Pharma Group
Zhejiang Zhenyuan Pharmaceutical
Beijing Polay Pharmaceuticals
Harbin Medisan Pharmaceutical
Hainan Jinrui Pharmaceutical
FLAGSHIP BIOTECH
Swissche Healthcare
Wasserbuger Artneimittelwerk GmbH
Takeda Austria GmbH
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
1 Study Coverage
1.1 Lornoxicam for Injection Product Introduction
1.2 Market by Specification
1.2.1 Global Lornoxicam for Injection Market Size Growth Rate by Specification, 2017 VS 2021 VS 2028
1.2.2 6 Pcs/Bottle
1.2.3 8 Pcs/Bottle
1.2.4 10 Pcs/Bottle
1.3 Market by Application
1.3.1 Global Lornoxicam for Injection Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Lornoxicam for Injection Sales Estimates and Forecasts 2017-2028
2.2 Global Lornoxicam for Injection Revenue Estimates and Forecasts 2017-2028
2.3 Global Lornoxicam for Injection Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Lornoxicam for Injection Sales by Region
2.4.1 Global Lornoxicam for Injection Sales by Region (2017-2022)
2.4.2 Global Sales Lornoxicam for Injection by Region (2023-2028)
2.5 Global Lornoxicam for Injection Revenue by Region
2.5.1 Global Lornoxicam for Injection Revenue by Region (2017-2022)
2.5.2 Global Lornoxicam for Injection Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Lornoxicam for Injection Sales by Manufacturers
3.1.1 Global Top Lornoxicam for Injection Manufacturers by Sales (2017-2022)
3.1.2 Global Lornoxicam for Injection Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Lornoxicam for Injection in 2021
3.2 Global Lornoxicam for Injection Revenue by Manufacturers
3.2.1 Global Lornoxicam for Injection Revenue by Manufacturers (2017-2022)
3.2.2 Global Lornoxicam for Injection Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Lornoxicam for Injection Revenue in 2021
3.3 Global Lornoxicam for Injection Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Lornoxicam for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Lornoxicam for Injection Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Specification
4.1 Global Lornoxicam for Injection Sales by Specification
4.1.1 Global Lornoxicam for Injection Historical Sales by Specification (2017-2022)
4.1.2 Global Lornoxicam for Injection Forecasted Sales by Specification (2023-2028)
4.1.3 Global Lornoxicam for Injection Sales Market Share by Specification (2017-2028)
4.2 Global Lornoxicam for Injection Revenue by Specification
4.2.1 Global Lornoxicam for Injection Historical Revenue by Specification (2017-2022)
4.2.2 Global Lornoxicam for Injection Forecasted Revenue by Specification (2023-2028)
4.2.3 Global Lornoxicam for Injection Revenue Market Share by Specification (2017-2028)
4.3 Global Lornoxicam for Injection Price by Specification
4.3.1 Global Lornoxicam for Injection Price by Specification (2017-2022)
4.3.2 Global Lornoxicam for Injection Price Forecast by Specification (2023-2028)
5 Market Size by Application
5.1 Global Lornoxicam for Injection Sales by Application
5.1.1 Global Lornoxicam for Injection Historical Sales by Application (2017-2022)
5.1.2 Global Lornoxicam for Injection Forecasted Sales by Application (2023-2028)
5.1.3 Global Lornoxicam for Injection Sales Market Share by Application (2017-2028)
5.2 Global Lornoxicam for Injection Revenue by Application
5.2.1 Global Lornoxicam for Injection Historical Revenue by Application (2017-2022)
5.2.2 Global Lornoxicam for Injection Forecasted Revenue by Application (2023-2028)
5.2.3 Global Lornoxicam for Injection Revenue Market Share by Application (2017-2028)
5.3 Global Lornoxicam for Injection Price by Application
5.3.1 Global Lornoxicam for Injection Price by Application (2017-2022)
5.3.2 Global Lornoxicam for Injection Price Forecast by Application (2023-2028)
6 North America
6.1 North America Lornoxicam for Injection Market Size by Specification
6.1.1 North America Lornoxicam for Injection Sales by Specification (2017-2028)
6.1.2 North America Lornoxicam for Injection Revenue by Specification (2017-2028)
6.2 North America Lornoxicam for Injection Market Size by Application
6.2.1 North America Lornoxicam for Injection Sales by Application (2017-2028)
6.2.2 North America Lornoxicam for Injection Revenue by Application (2017-2028)
6.3 North America Lornoxicam for Injection Market Size by Country
6.3.1 North America Lornoxicam for Injection Sales by Country (2017-2028)
6.3.2 North America Lornoxicam for Injection Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Lornoxicam for Injection Market Size by Specification
7.1.1 Europe Lornoxicam for Injection Sales by Specification (2017-2028)
7.1.2 Europe Lornoxicam for Injection Revenue by Specification (2017-2028)
7.2 Europe Lornoxicam for Injection Market Size by Application
7.2.1 Europe Lornoxicam for Injection Sales by Application (2017-2028)
7.2.2 Europe Lornoxicam for Injection Revenue by Application (2017-2028)
7.3 Europe Lornoxicam for Injection Market Size by Country
7.3.1 Europe Lornoxicam for Injection Sales by Country (2017-2028)
7.3.2 Europe Lornoxicam for Injection Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Lornoxicam for Injection Market Size by Specification
8.1.1 Asia Pacific Lornoxicam for Injection Sales by Specification (2017-2028)
8.1.2 Asia Pacific Lornoxicam for Injection Revenue by Specification (2017-2028)
8.2 Asia Pacific Lornoxicam for Injection Market Size by Application
8.2.1 Asia Pacific Lornoxicam for Injection Sales by Application (2017-2028)
8.2.2 Asia Pacific Lornoxicam for Injection Revenue by Application (2017-2028)
8.3 Asia Pacific Lornoxicam for Injection Market Size by Region
8.3.1 Asia Pacific Lornoxicam for Injection Sales by Region (2017-2028)
8.3.2 Asia Pacific Lornoxicam for Injection Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Lornoxicam for Injection Market Size by Specification
9.1.1 Latin America Lornoxicam for Injection Sales by Specification (2017-2028)
9.1.2 Latin America Lornoxicam for Injection Revenue by Specification (2017-2028)
9.2 Latin America Lornoxicam for Injection Market Size by Application
9.2.1 Latin America Lornoxicam for Injection Sales by Application (2017-2028)
9.2.2 Latin America Lornoxicam for Injection Revenue by Application (2017-2028)
9.3 Latin America Lornoxicam for Injection Market Size by Country
9.3.1 Latin America Lornoxicam for Injection Sales by Country (2017-2028)
9.3.2 Latin America Lornoxicam for Injection Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Lornoxicam for Injection Market Size by Specification
10.1.1 Middle East and Africa Lornoxicam for Injection Sales by Specification (2017-2028)
10.1.2 Middle East and Africa Lornoxicam for Injection Revenue by Specification (2017-2028)
10.2 Middle East and Africa Lornoxicam for Injection Market Size by Application
10.2.1 Middle East and Africa Lornoxicam for Injection Sales by Application (2017-2028)
10.2.2 Middle East and Africa Lornoxicam for Injection Revenue by Application (2017-2028)
10.3 Middle East and Africa Lornoxicam for Injection Market Size by Country
10.3.1 Middle East and Africa Lornoxicam for Injection Sales by Country (2017-2028)
10.3.2 Middle East and Africa Lornoxicam for Injection Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Suzhou Tianma Pharma Group
11.1.1 Suzhou Tianma Pharma Group Corporation Information
11.1.2 Suzhou Tianma Pharma Group Overview
11.1.3 Suzhou Tianma Pharma Group Lornoxicam for Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Suzhou Tianma Pharma Group Lornoxicam for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Suzhou Tianma Pharma Group Recent Developments
11.2 Zhejiang Zhenyuan Pharmaceutical
11.2.1 Zhejiang Zhenyuan Pharmaceutical Corporation Information
11.2.2 Zhejiang Zhenyuan Pharmaceutical Overview
11.2.3 Zhejiang Zhenyuan Pharmaceutical Lornoxicam for Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Zhejiang Zhenyuan Pharmaceutical Lornoxicam for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Zhejiang Zhenyuan Pharmaceutical Recent Developments
11.3 Beijing Polay Pharmaceuticals
11.3.1 Beijing Polay Pharmaceuticals Corporation Information
11.3.2 Beijing Polay Pharmaceuticals Overview
11.3.3 Beijing Polay Pharmaceuticals Lornoxicam for Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Beijing Polay Pharmaceuticals Lornoxicam for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Beijing Polay Pharmaceuticals Recent Developments
11.4 Harbin Medisan Pharmaceutical
11.4.1 Harbin Medisan Pharmaceutical Corporation Information
11.4.2 Harbin Medisan Pharmaceutical Overview
11.4.3 Harbin Medisan Pharmaceutical Lornoxicam for Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Harbin Medisan Pharmaceutical Lornoxicam for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Harbin Medisan Pharmaceutical Recent Developments
11.5 Hainan Jinrui Pharmaceutical
11.5.1 Hainan Jinrui Pharmaceutical Corporation Information
11.5.2 Hainan Jinrui Pharmaceutical Overview
11.5.3 Hainan Jinrui Pharmaceutical Lornoxicam for Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Hainan Jinrui Pharmaceutical Lornoxicam for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Hainan Jinrui Pharmaceutical Recent Developments
11.6 FLAGSHIP BIOTECH
11.6.1 FLAGSHIP BIOTECH Corporation Information
11.6.2 FLAGSHIP BIOTECH Overview
11.6.3 FLAGSHIP BIOTECH Lornoxicam for Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 FLAGSHIP BIOTECH Lornoxicam for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 FLAGSHIP BIOTECH Recent Developments
11.7 Swissche Healthcare
11.7.1 Swissche Healthcare Corporation Information
11.7.2 Swissche Healthcare Overview
11.7.3 Swissche Healthcare Lornoxicam for Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Swissche Healthcare Lornoxicam for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Swissche Healthcare Recent Developments
11.8 Wasserbuger Artneimittelwerk GmbH
11.8.1 Wasserbuger Artneimittelwerk GmbH Corporation Information
11.8.2 Wasserbuger Artneimittelwerk GmbH Overview
11.8.3 Wasserbuger Artneimittelwerk GmbH Lornoxicam for Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Wasserbuger Artneimittelwerk GmbH Lornoxicam for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Wasserbuger Artneimittelwerk GmbH Recent Developments
11.9 Takeda Austria GmbH
11.9.1 Takeda Austria GmbH Corporation Information
11.9.2 Takeda Austria GmbH Overview
11.9.3 Takeda Austria GmbH Lornoxicam for Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Takeda Austria GmbH Lornoxicam for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Takeda Austria GmbH Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Lornoxicam for Injection Industry Chain Analysis
12.2 Lornoxicam for Injection Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Lornoxicam for Injection Production Mode & Process
12.4 Lornoxicam for Injection Sales and Marketing
12.4.1 Lornoxicam for Injection Sales Channels
12.4.2 Lornoxicam for Injection Distributors
12.5 Lornoxicam for Injection Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Lornoxicam for Injection Industry Trends
13.2 Lornoxicam for Injection Market Drivers
13.3 Lornoxicam for Injection Market Challenges
13.4 Lornoxicam for Injection Market Restraints
14 Key Findings in The Global Lornoxicam for Injection Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer